Cancer News and Research

Latest Cancer News and Research

Tanning solariums exposing people to UV radiation six times the strength of midday sun: Study

According to the latest research, tanning sun beds can deliver wildly different doses of UV radiation, with some exposing users to levels up to six times the strength of the midday sun. Worst part of it that most users are unaware of this say experts. An audit of beds in Sydney and Melbourne found some deliver twice the dose of radiation as others classed in lower categories. The audits took place in Victoria and NSW.

15 May 2011

AgenoLAB acquires Roche´s RTCA Cardio Instrument

AgenoLAB, the Stuttgart-based service provider, is the first company in Germany to expand its service offering with the latest cell analysis technology from Roche. The company will use the RTCA Cardio Instrument to complement their analytical service portfolio for drug development.

13 May 2011

The Leonardo da Vinci Prize competition invites project submissions

International philanthropists, prestigious Universities, Hospitals, Order of Physicians, Public Administrations support and sponsor this initiative to follow scientific procedures to identify solutions with the highest potential to reduce premature cancer death and cost.

13 May 2011

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland, the first clinical site in Poland and the first center in the EU.

13 May 2011

Pro-Pharmaceuticals reports net loss of $2.7 million for first quarter 2011

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the first quarter, ended March 31, 2011.

13 May 2011

PAF, Breakaway from Cancer partner for awareness campaign

The Patient Advocate Foundation – a national non-profit organization that provides professional case management services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to partner with Breakaway from Cancer, a national fundraising and educational initiative founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, a world-class professional cycling competition, to raise awareness of the important resources available to cancer patients including prevention, education, patient care, advocacy, financial support and survivorship.

13 May 2011

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA) to begin clinical study of Ad-RTS-IL-12, a novel DNA-based therapeutic candidate.

13 May 2011

Nine nurses earn UC Irvine recognition for patient care, education and guidance, teamwork

Each year during National Nurses Week, UC Irvine Medical Center honors nurses who demonstrate excellence in patient care, education and guidance, mentorship, and teamwork.

13 May 2011

Researchers untangle two distinct ways in which tumor-suppressor protein works

Researchers at the Stanford University School of Medicine have untangled two distinct ways in which a common, naturally occurring "tumor-suppressor" protein works.

13 May 2011

Notum gene plays a key role in planarian's regeneration decision-making process

A seldom-studied gene known as notum plays a key role in the planarian's regeneration decision-making process, according to Whitehead Institute scientists. Protein from this gene determines whether a head or tail will regrow at appropriate amputation sites.

13 May 2011

Midbrain habenula region plays a key role in nicotine dependence

A person's vulnerability to nicotine addiction appears to have a genetic basis, at least in part. A region in the midbrain called the habenula plays a key role in this process, as Dr. In-s Iba-ez-Tallon and her team from the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now shown.

13 May 2011

New study sheds light on origins of myeloid leukemia

A new study by the NYU Cancer Institute, an NCI-designated cancer center, sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults.

13 May 2011

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

13 May 2011